Zsírmáj (MASLD/MASH): vizsgálatok itt: Kazahsztán
1 of 3 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- No phaseTaking peopleClinical Profile of Patients With MASLD in Kazakhstan and Clinical Effectiveness of Ursosan in Almaty
- Where
- Aktau, Aktobe, Almaty, Astana, Shymkent
- Életkor
- 18 év to 65 év
- People
- 420
- Run by
- Kazakh Association of Internal Medicine Specialists
See details and how to joinNCT07889999